يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Khaled Messaoudi"', وقت الاستعلام: 0.87s تنقيح النتائج
  1. 1
    Toward an effective strategy in glioblastoma treatment. Part II: RNA interference as a promising way to sensitize glioblastomas to temozolomide

    المؤلفون: Anne Clavreul, Frédéric Lagarce, Khaled Messaoudi

    المساهمون: Micro et Nanomédecines Biomimétiques (MINT), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Bretagne Loire (UBL), Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), Univ Angers, Okina

    المصدر: Drug Discovery Today
    Drug Discovery Today, 2015, 20 (6), pp.772-9. ⟨10.1016/j.drudis.2015.02.014⟩
    Drug Discovery Today, Elsevier, 2015, 20 (6), pp.772-9. ⟨10.1016/j.drudis.2015.02.014⟩

    مصطلحات موضوعية: [SDV.NEU.NB]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology, [SDV.CAN]Life Sciences [q-bio]/Cancer, Tumor cells, Biology, Bioinformatics, RNAi Therapeutics, Immune system, [SDV.CAN] Life Sciences [q-bio]/Cancer, RNA interference, Drug Discovery, Biomarkers, Tumor, Temozolomide, medicine, Animals, Humans, Antineoplastic Agents, Alkylating, Pharmacology, Regulation of gene expression, Brain Neoplasms, Mechanism (biology), fungi, Gene Transfer Techniques, [SDV.NEU.NB] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC]/Neurobiology, medicine.disease, 3. Good health, Dacarbazine, Gene Expression Regulation, Neoplastic, Drug Resistance, Neoplasm, [SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, medicine.drug, Glioblastoma

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf7da3107dc826a7e8de6a937609db00Test
    https://doi.org/10.1016/j.drudis.2015.02.014Test


    أضف إلى المفضلة
  2. 2
    Toward an effective strategy in glioblastoma treatment. Part I: resistance mechanisms and strategies to overcome resistance of glioblastoma to temozolomide

    المؤلفون: Frédéric Lagarce, Anne Clavreul, Khaled Messaoudi

    المساهمون: Micro et Nanomédecines Biomimétiques (MINT), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Bretagne Loire (UBL), Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM), Univ Angers, Okina

    المصدر: Drug Discovery Today
    Drug Discovery Today, Elsevier, 2015, 20 (7), pp.899-905. ⟨10.1016/j.drudis.2015.02.011⟩
    Drug Discovery Today, 2015, 20 (7), pp.899-905. ⟨10.1016/j.drudis.2015.02.011⟩

    مصطلحات موضوعية: medicine.medical_treatment, [SDV.CAN]Life Sciences [q-bio]/Cancer, Drug resistance, Pharmacology, Structure-Activity Relationship, [SDV.CAN] Life Sciences [q-bio]/Cancer, Glioma, Drug Discovery, medicine, Biomarkers, Tumor, Temozolomide, PTEN, Animals, Humans, Genetic Predisposition to Disease, Epidermal growth factor receptor, [SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], Antineoplastic Agents, Alkylating, Chemotherapy, biology, Molecular Structure, Brain Neoplasms, medicine.disease, 3. Good health, Radiation therapy, Dacarbazine, Phenotype, Drug Resistance, Neoplasm, [SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, Drug Design, Cancer research, biology.protein, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, Mdm2, [SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], Glioblastoma, medicine.drug, Signal Transduction

    وصف الملف: application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95c4ffe4b5db0124708d774f31f19e4aTest
    https://pubmed.ncbi.nlm.nih.gov/25744176Test


    أضف إلى المفضلة
  3. 3
    Anti-epidermal growth factor receptor siRNA carried by chitosan-transacylated lipid nanocapsules increases sensitivity of glioblastoma cells to temozolomide

    المؤلفون: Frédéric Lagarce, Jean-Pierre Benoit, Khaled Messaoudi, Patrick Saulnier, Kim Boesen

    المساهمون: Micro et Nanomédecines Biomimétiques (MINT), Université d'Angers (UA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Bretagne Loire (UBL), Département de Pharmacie [CHU d'Angers], Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM), Univ Angers, Okina

    المصدر: International Journal of Nanomedicine
    International Journal of Nanomedicine, Dove Medical Press, 2014, 9, pp.1479-90. ⟨10.2147/IJN.S59134⟩
    International Journal of Nanomedicine, 2014, 9, pp.1479-90. ⟨10.2147/IJN.S59134⟩

    مصطلحات موضوعية: Acylation, EGFR, [SDV]Life Sciences [q-bio], Cell, Biophysics, Pharmaceutical Science, Bioengineering, temozolomide, Biology, Pharmacology, Nanocapsules, Biomaterials, Transacylation, International Journal of Nanomedicine, Cell Line, Tumor, Drug Discovery, medicine, Humans, Gene Silencing, Epidermal growth factor receptor, Particle Size, RNA, Small Interfering, Cytotoxicity, Antineoplastic Agents, Alkylating, Original Research, Gene knockdown, lipid nanocapsules, Temozolomide, Organic Chemistry, glioblastoma, Drug Synergism, General Medicine, Transfection, Lipids, 3. Good health, Dacarbazine, ErbB Receptors, [SDV] Life Sciences [q-bio], Treatment Outcome, medicine.anatomical_structure, siRNA, biology.protein, chitosan, medicine.drug

    وصف الملف: text/html; application/pdf

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10d700b213ea3fbef74e843600d6e713Test
    https://doi.org/10.2147/ijn.s59134Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث